Chris Yun, BS

Chris is an experienced and versatile clinical professional with 18 years’ experience in global drug development in pharmaceutical, biotech and CROs. Most recently, Chris has served as the director of clinical development for a biotech company developing a CV/metabolic compound in ACS and diabetic patients. Chris was involved in the full life cycle of this compound overseeing the clinical program including several phase I and II trials through completion of two pivotal Phase III global trials. Chris has extensive experience in cardiovascular drug development throughout his career starting as a Research Coordinator at a cardiology department where he was involved in all aspects of clinical research activities. Chris has served as a global PM for 6 global clinical trials over the past 10 years at a CRO and a biotech company in CNS, oncology and cardiovascular/metabolic indications. Expertise in clinical operations, process improvement and vendor management are some of the key skills Chris brings to Kinexum. Chris’ demonstrated success in building, mentoring, and coaching global teams from diverse international backgrounds will be an asset for Kinexum. He is an innovator in conflict resolution and mediation with aptitude for motivating individuals to work in cohesive teams. Chris holds a B.S. in Exercise Physiology from the University of Rhode Island.